A deeper characterization of the function and downstream signaling pathways influenced by HOTTIP deregulation is being investigated in our team, which may provide novel insights into the mechanisms of SCLC pathogenesis and possibly leading to the development of new therapeutic agents. Here, HOTTIP is linked to small cell lung carcinoma.